COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 194: Articles 1931-1940  | Next

Variant mutation in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation
Kubinski, H. C., Despres, H. W., Johnson, B. A., Schmidt, M. M., Jaffrani, S. A., Mills, M. G., Lokugamage, K., Dumas, C. M., Shirley, D. J., Estes, L. K., Pekosz, A., Crothers, J. W., Roychoudhury, P., Greninger, A. L., Jerome, K. R., Martorelli Di Genova, B., Walker, D. H., Ballif, B. A., Ladinsky, M. S., Bjorkman, P. J., Menachery, V. D., Bruce, E. A.
10.1101/2024.03.08.584120 — Posted: 2024-03-11
SARS-CoV-2 Genetic Variants and Patient Factors Associated with Hospitalization Risk
Korves, T., Stein, D., Walburger, D., Adamusiak, T., Roberts, S.
10.1101/2024.03.08.24303818 — Posted: 2024-03-10
Planning and adjusting the COVID-19 booster vaccination campaign to reduce disease burden
Di Domenico, L., Goldberg, Y., Colizza, V.
10.1101/2024.03.08.24303201 — Posted: 2024-03-10
RAPID POINT-OF-CARE DETECTION OF SARS-COV-2 BY ALVEO BE.WELL PLATFORM: ANALYTICAL AND CLINICAL EVALUATIONS
Fang, R., Coleman, S., Kwok, C., Heisser, H., Wang, T., Kim, L. J., Coopersmith, A., Crawford, D., Ha, K., Gaiteri, J. C., Chiang, Y.-M.
10.1101/2024.03.07.24303877 — Posted: 2024-03-09
Prevalence and seroprevalence of COVID-19 infection among older people: A scoping review based on population-based studies in 2020-2022
Lei, J., Soe, P.
10.1101/2024.03.08.24303942 — Posted: 2024-03-09
Learn!Bio - A time-limited cross-sectional study on biosciences students' pathway to resilience during and post the Covid-19 pandemic at an UK university from 2020-2023 and insights into future teaching approaches.
Andrews, K., Stoneley, R., Eckl, K.
10.1101/2024.03.06.583815 — Posted: 2024-03-08
Understanding Food Insecurity in Kinshasa During the COVID-19 Pandemic
Akilimali, P., Kazenza, B., Kabasubabo, F., Egbende, L., Botomba, S., Kayembe, D. M., Mbunga, B. K., Tran, N. T., Mashinda, D. K.
10.1101/2024.03.06.24303901 — Posted: 2024-03-08
Online media use and COVID-19 vaccination in real-world personal networks
Oana, I., Hancean, M.-G., Perc, M., Lerner, J., Pintoiu-Mihaila, B.-E., Geanta, M., Molina, J. L., Tinca, I., Espina, C.
10.1101/2024.03.07.24303919 — Posted: 2024-03-08
Immune history influences SARS-CoV-2 booster impacts: the role of efficacy and redundancy
Larsen, S. L., Noor, I., West, H., Chandra, E., Martinez, P. P., Kraay, A. N. M.
10.1101/2024.03.06.24303879 — Posted: 2024-03-08
SARS-CoV-2 antibody prevalence by industry, workplace characteristics, and workplace infection prevention and control measures, North Carolina, 2021 to 2022
Gigot, C., Pisanic, N., Spicer, K., Davis, M. F., Kruczynski, K., Gregory Rivera, M., Koehler, K., Hall, D. J., Hall, D. J., Heaney, C. D.
10.1101/2024.03.06.24303821 — Posted: 2024-03-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).